Medical Cannabis Users Are Older and Use More Frequently Than Recreational-Only Users, National Study Finds
Medical cannabis use frequency is higher than recreational-only use across all adult age groups. This national study highlights that medical users consume cannabis more consistently and frequently. Understanding medical cannabis use frequency is crucial…
Health-related quality of life in patients receiving medicinal cannabis: systematic review and meta-analysis of primary research findings 2015-2025.
A comprehensive systematic review and meta-analysis examining medicinal cannabis quality of life outcomes found consistent improvements across chronic conditions. The research analyzed validated HRQL measures from 2015-2025, showing benefits in short,…
CBD reduces chronic pain in new randomized controlled trial
CBD pain research reveals clinically significant reductions in chronic pain in a new randomized controlled trial. This study provides evidence supporting CBD as a potential adjunctive therapy. Clinicians can now reference this CBD pain research when…
Federal Judge Weighs Medicare Cannabinoid Reimbursement Decision
A federal judge is reviewing Medicare cannabinoid reimbursement policies that could expand access to hemp-derived cannabis medications. This decision impacts coverage for cannabinoids without FDA approval. Clinicians and patients await clarity on…
How Federal Rescheduling Could Lower Medical Marijuana Costs in Missouri
The federal reschedule medical marijuana cost impact could significantly reduce prices in Missouri by eliminating the 280E tax burden. This change would improve patient access to affordable cannabis treatments. Lower costs may enhance treatment adherence…
Cannabinoid Pain Relief: Evidence-Based Clinical Guide
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, with preclinical evidence showing reduced pain-related neuronal activity. Current research demonstrates that cannabinoid…
Endocannabinoid System Clinical Research in Back Pain
Clinical research on full-spectrum cannabis extract back pain treatment shows meaningful pain reduction in chronic low back pain patients. The VER-01 extract demonstrated safety and tolerability over 12 weeks. These findings support further investigation…
Endocannabinoid System Clinical Research: Pain Management Trial
The full-spectrum cannabis extract pain trial demonstrated significant pain reduction in adults with chronic low back pain. VER-01 was well-tolerated with manageable adverse effects. These findings support full-spectrum cannabis extract pain as a…
Cannabis Balms for AIMSS: Clinical Trial Evidence
A small clinical trial found topical cannabis balms safe and feasible for women with breast cancer experiencing aromatase inhibitor joint pain. The study shows cannabinoid products are tolerated by this population. Larger trials are needed to confirm…
Cannabidiol vs Placebo for Fibromyalgia: Clinical Trial
This cannabidiol fibromyalgia clinical trial evidence evaluates CBD's effectiveness compared to placebo in reducing fibromyalgia pain. The study found no superiority of cannabidiol over placebo. Current evidence remains insufficient to support CBD as an…